FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/23/2026
Back to search
Official data from USPTO
HIZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/23/2026
Trademark type
Combined
Nice classes
5
Filing date
01/11/2024
Registration date
12/30/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
SG
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the blue outline of a circle containing a blue zigzag design, above the wording "HIZYME" in blue stylized font, all on a white background.
Holders and representatives
Holders
BIONUTRI PTE. LTD.
Representatives
Brian Schar CrossPond Law
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations containing enzymes for medical purposesfor use in the treatment of metabolicinflammatorydigestive disorders; chemical preparations containing enzymes for veterinary purposesfor enhancing proteinstarchfiber utilization in animal nutrition; animal feed additivesenzymes for use in animal feeds to assist in digestion; coenzyme Q10 dietary supplements; enzyme food supplements for medical purposes; enzymes for medical or veterinary usefor supporting gut health and immune function in companion and production animals; enzymes for medical purposes; pharmaceutical preparations containing enzymes for skin care and for treating diabetes; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for medical purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for veterinary purposes; recombinant human enzymes being biochemical preparations for medical purposesfor the treatment of pancreatic exocrine insufficiencyGaucher disease and lysosomal storage disorders.
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/06/2026
FIMP
FINAL DISPOSITION PROCESSED
07/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/30/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/30/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/30/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2025
PUBO
PUBLISHED FOR OPPOSITION
11/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/13/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/19/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/18/2025
GNFR
FINAL REFUSAL E-MAILED
09/18/2025
CNFR
FINAL REFUSAL WRITTEN
09/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/03/2025
RFNT
REFUSAL PROCESSED BY IB
08/29/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2025
RFRR
REFUSAL PROCESSED BY MPU
08/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/07/2025
CNRT
NON-FINAL ACTION WRITTEN
08/20/2024
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
08/20/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/13/2024
CNRT
NON-FINAL ACTION WRITTEN
08/12/2024
DOCK
ASSIGNED TO EXAMINER
08/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/04/2024
Continuous trademark protection
Get notified about every new filing that threatens HIZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.